Igel'nik A M
Urol Nefrol (Mosk). 1993 Mar-Apr(2):29-31.
Renal artery embolization (RAE) was carried out in 24 renal carcinoma patients aged 60-81. Nineteen of them underwent nephrectomy. Six lethal outcomes were due to RAE complications, of which renal failure and/or purulent inflammation were most frequent (37.5% and 29.2%, respectively). Post-nephrectomy patients as compared to those with prior RAE developed postoperative complications, acute renal failure or aggravation of chronic renal failure 1.4, 1.9, 2.5 times less frequently, respectively. The lethality among them was also less (1.4 times). A 5-year survival for those operated after RAE reached 61.7%, without RAE 30.6%. Despite better results of operative treatment following RAE, it is recommended only for correction of macrohematuria in failure of conservative hemostatic therapy because of high risk of life threatening complications in senile patients. It may be also used in contraindications to surgery or in need of preoperative preparation in the presence of associated diseases.
对24例年龄在60 - 81岁的肾癌患者实施了肾动脉栓塞术（RAE）。其中19例接受了肾切除术。6例死亡病例归因于RAE并发症，其中肾衰竭和/或化脓性炎症最为常见（分别为37.5%和29.2%）。与术前接受RAE的患者相比，肾切除术后患者术后并发症、急性肾衰竭或慢性肾衰竭加重的发生率分别低1.4倍、1.9倍和2.5倍。他们的死亡率也较低（1.4倍）。接受RAE后手术患者的5年生存率达到61.7%，未接受RAE者为30.6%。尽管RAE后的手术治疗效果较好，但由于老年患者发生危及生命并发症的风险较高，仅建议在保守止血治疗失败以纠正大出血时使用。它也可用于手术禁忌或存在相关疾病需要术前准备的情况。
